http://nro.sagepub.com/content/21/4/337.abstract?&
- 1Department of Neurology, Changzhou No. 2 People’s Hospital, The Affiliated Hospital of Nanjing Medical University, Changzhou, China
- 2Key Laboratory of Translational Neuroscience, Zhoukou Normal University, Zhoukou China
- 3College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou China
- 4Department of Physiology and Neuroscience Program, Michigan State University, East Lansing, MI, USA
- Xianju Zhou, Department of Neurology, Changzhou No.2 People’s Hospital, the affiliated Hospital of Nanjing Medical University, 29 Xinglong Alley, Changzhou, 21003, China. E-mail: hippocampus2007@gmail.com and Hongbing Wang, Department of Physiology and Neuroscience Program, Michigan State University, 567 Wilson Road, Room 2201 BPS Building, East Lansing, MI 48824, USA. Email: wangho@msu.edu
Abstract
It is generally accepted that proper activation of N-methyl-d-aspartate
receptors (NMDARs) promotes neuronal survival and supports
neuroplasticity, and excessive NMDAR activation leads
to pathological outcomes and neurodegeneration. As
NMDARs are found at both synaptic and extrasynaptic sites, there is
significant
interest in determining how NMDARs at different
subcellular locations differentially regulate physiological as well as
pathological
functions. Better understanding of this issue may
support the development of therapeutic strategies to attenuate neuronal
death or promote normal brain function. Although
the current prevailing theory emphasizes the major role of extrasynaptic
NMDARs in neurodegeneration, there is growing
evidence indicating the involvement of synaptic receptors. It is also
evident
that physiological functions of the brain also
involve extrasynaptic NMDARs. Our recent studies demonstrate that the
degree
of cell death following neuronal insults depends on
the magnitude and duration of synaptic and extrasynaptic receptor
co-activation.
These new results underscore the importance of
revisiting the function of extrasynaptic NMDARs in cell fate.
Furthermore,
the development of antagonists that preferentially
inhibit synaptic or extrasynaptic receptors may better clarify the role
of NMDARs in neurodegeneration.
No comments:
Post a Comment